1.
Rubini N, Ensina L, Silva E, Sano F, Solé D. Effectiveness and safety of Omalizumab in the treatment of chronic spontaneous urticaria: Systematic review and meta-analysis. Allergol Immunopathol [Internet]. 2019 Dec. 15 [cited 2025 Sep. 10];47(6):515-22. Available from: https://all-imm.com/index.php/aei/article/view/264